![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Real-World Utilization of HIV Pre-Exposure Prophylaxis
(PrEP) by Cisgender and Transgender Individuals in the United States
|
|
|
Li Tao,1 Christoph Carter,1 Moupali Das,1 Jen Thorburn,2 Julie Paone,2 Amanda Kong,2 Chris Bush,2 Deesha Patel2
1Gilead Sciences, Inc., Foster City, California, USA; 2Aetion, Inc., New York, New York, USA
individuals not identified as TGM or TGW were classified as cisgender men (CGM) or women (CGW)
![0731221copy](../images/073122/073122-1/0731221copy.gif)
![0731222copy](../images/073122/073122-1/0731222copy.gif)
![0731223copy](../images/073122/073122-1/0731223copy.gif)
![0731224copy](../images/073122/073122-1/0731224copy.gif)
![0731225copy](../images/073122/073122-1/0731225copy.gif)
![0731226copy](../images/073122/073122-1/0731226copy.gif)
![0731227copy](../images/073122/073122-1/0731227copy.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|